These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 21703428)

  • 1. Targeting protease-activated receptor-1 with cell-penetrating pepducins in lung cancer.
    Cisowski J; O'Callaghan K; Kuliopulos A; Yang J; Nguyen N; Deng Q; Yang E; Fogel M; Tressel S; Foley C; Agarwal A; Hunt SW; McMurry T; Brinckerhoff L; Covic L
    Am J Pathol; 2011 Jul; 179(1):513-23. PubMed ID: 21703428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blockade of PAR1 signaling with cell-penetrating pepducins inhibits Akt survival pathways in breast cancer cells and suppresses tumor survival and metastasis.
    Yang E; Boire A; Agarwal A; Nguyen N; O'Callaghan K; Tu P; Kuliopulos A; Covic L
    Cancer Res; 2009 Aug; 69(15):6223-31. PubMed ID: 19622769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prohibitin is involved in the activated internalization and degradation of protease-activated receptor 1.
    Wang YJ; Guo XL; Li SA; Zhao YQ; Liu ZC; Lee WH; Xiang Y; Zhang Y
    Biochim Biophys Acta; 2014 Jul; 1843(7):1393-401. PubMed ID: 24732013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protease-Activated Receptor 1 as Therapeutic Target in Breast, Lung, and Ovarian Cancer: Pepducin Approach.
    Covic L; Kuliopulos A
    Int J Mol Sci; 2018 Jul; 19(8):. PubMed ID: 30065181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization and functional activity of thrombin receptors in the human lens.
    James C; Collison DJ; Duncan G
    Invest Ophthalmol Vis Sci; 2005 Mar; 46(3):925-32. PubMed ID: 15728549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Galectin-1 promotes lung cancer progression and chemoresistance by upregulating p38 MAPK, ERK, and cyclooxygenase-2.
    Chung LY; Tang SJ; Sun GH; Chou TY; Yeh TS; Yu SL; Sun KH
    Clin Cancer Res; 2012 Aug; 18(15):4037-47. PubMed ID: 22696230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct activity of peptide mimetic intracellular ligands (pepducins) for proteinase-activated receptor-1 in multiple cells/tissues.
    Kubo S; Ishiki T; Doe I; Sekiguchi F; Nishikawa H; Kawai K; Matsui H; Kawabata A
    Ann N Y Acad Sci; 2006 Dec; 1091():445-59. PubMed ID: 17341635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of metastasis-associated in colon cancer 1 inhibition by small hairpin RNA on ovarian carcinoma OVCAR-3 cells.
    Zhang R; Shi H; Chen Z; Wu Q; Ren F; Huang H
    J Exp Clin Cancer Res; 2011 Sep; 30(1):83. PubMed ID: 21923915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting A549 lung adenocarcinoma cell growth and invasion with protease‑activated receptor‑1 siRNA.
    Wu Z; Zeng Y; Zhong M; Wang B
    Mol Med Rep; 2014 May; 9(5):1787-93. PubMed ID: 24604247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The activation of Proteinase-Activated Receptor-1 (PAR1) mediates gastric cancer cell proliferation and invasion.
    Fujimoto D; Hirono Y; Goi T; Katayama K; Matsukawa S; Yamaguchi A
    BMC Cancer; 2010 Aug; 10():443. PubMed ID: 20723226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered protease-activated receptor-1 expression and signaling in a malignant pleural mesothelioma cell line, NCI-H28, with homozygous deletion of the β-catenin gene.
    Fazzini A; D'Antongiovanni V; Giusti L; Da Valle Y; Ciregia F; Piano I; Caputo A; D'Ursi AM; Gargini C; Lucacchini A; Mazzoni MR
    PLoS One; 2014; 9(11):e111550. PubMed ID: 25364818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interdicting protease-activated receptor-2-driven inflammation with cell-penetrating pepducins.
    Sevigny LM; Zhang P; Bohm A; Lazarides K; Perides G; Covic L; Kuliopulos A
    Proc Natl Acad Sci U S A; 2011 May; 108(20):8491-6. PubMed ID: 21536878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protease-activated receptor-2 is essential for factor VIIa and Xa-induced signaling, migration, and invasion of breast cancer cells.
    Morris DR; Ding Y; Ricks TK; Gullapalli A; Wolfe BL; Trejo J
    Cancer Res; 2006 Jan; 66(1):307-14. PubMed ID: 16397244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allosteric Activation of a G Protein-coupled Receptor with Cell-penetrating Receptor Mimetics.
    Zhang P; Leger AJ; Baleja JD; Rana R; Corlin T; Nguyen N; Koukos G; Bohm A; Covic L; Kuliopulos A
    J Biol Chem; 2015 Jun; 290(25):15785-15798. PubMed ID: 25934391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiapoptotic activity of autocrine interleukin-22 and therapeutic effects of interleukin-22-small interfering RNA on human lung cancer xenografts.
    Zhang W; Chen Y; Wei H; Zheng C; Sun R; Zhang J; Tian Z
    Clin Cancer Res; 2008 Oct; 14(20):6432-9. PubMed ID: 18927282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteinase-activated receptors induce interleukin-8 expression by intestinal epithelial cells through ERK/RSK90 activation and histone acetylation.
    Wang H; Moreau F; Hirota CL; MacNaughton WK
    FASEB J; 2010 Jun; 24(6):1971-80. PubMed ID: 20065107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue factor induction by protease-activated receptor 1 requires intact caveolin-enriched membrane microdomains in human endothelial cells.
    Banfi C; Brioschi M; Barcella S; Pignieri A; Parolari A; Biglioli P; Tremoli E; Mussoni L
    J Thromb Haemost; 2007 Dec; 5(12):2437-44. PubMed ID: 17848177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting a metalloprotease-PAR1 signaling system with cell-penetrating pepducins inhibits angiogenesis, ascites, and progression of ovarian cancer.
    Agarwal A; Covic L; Sevigny LM; Kaneider NC; Lazarides K; Azabdaftari G; Sharifi S; Kuliopulos A
    Mol Cancer Ther; 2008 Sep; 7(9):2746-57. PubMed ID: 18790755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of expression of innate immunity markers CXCL5/ENA-78 and CCL20/MIP3alpha by protease-activated receptors (PARs) in human gingival epithelial cells.
    Rohani MG; Beyer RP; Hacker BM; Dommisch H; Dale BA; Chung WO
    Innate Immun; 2010 Apr; 16(2):104-14. PubMed ID: 19567485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dipyridamole prevents triple-negative breast-cancer progression.
    Spano D; Marshall JC; Marino N; De Martino D; Romano A; Scoppettuolo MN; Bello AM; Di Dato V; Navas L; De Vita G; Medaglia C; Steeg PS; Zollo M
    Clin Exp Metastasis; 2013 Jan; 30(1):47-68. PubMed ID: 22760522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.